Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

ADAM10 and ADAM17 regulate EGFR, c-Met and TNF RI signalling in liver regeneration and fibrosis

O. Zbodakova, K. Chalupsky, L. Sarnova, P. Kasparek, M. Jirouskova, M. Gregor, R. Sedlacek

. 2021 ; 11 (1) : 11414. [pub] 20210601

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

ADAM10 and ADAM17 are proteases that affect multiple signalling pathways by releasing molecules from the cell surface. As their substrate specificities partially overlaps, we investigated their concurrent role in liver regeneration and fibrosis, using three liver-specific deficient mouse lines: ADAM10- and ADAM17-deficient lines, and a line deficient for both proteases. In the model of partial hepatectomy, double deficient mice exhibited decreased AKT phosphorylation, decreased release of EGFR activating factors and lower shedding of HGF receptor c-Met. Thus, simultaneous ablation of ADAM10 and ADAM17 resulted in inhibited EGFR signalling, while HGF/c-Met signalling pathway was enhanced. In contrast, antagonistic effects of ADAM10 and ADAM17 were observed in the model of chronic CCl4 intoxication. While ADAM10-deficient mice develop more severe fibrosis manifested by high ALT, AST, ALP and higher collagen deposition, combined deficiency of ADAM10 and ADAM17 surprisingly results in comparable degree of liver damage as in control littermates. Therefore, ADAM17 deficiency is not protective in fibrosis development per se, but can ameliorate the damaging effect of ADAM10 deficiency on liver fibrosis development. Furthermore, we show that while ablation of ADAM17 resulted in decreased shedding of TNF RI, ADAM10 deficiency leads to increased levels of soluble TNF RI in serum. In conclusion, hepatocyte-derived ADAM10 and ADAM17 are important regulators of growth receptor signalling and TNF RI release, and pathological roles of these proteases are dependent on the cellular context.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004298
003      
CZ-PrNML
005      
20220127145352.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-021-90716-3 $2 doi
035    __
$a (PubMed)34075077
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Zbodakova, Olga $u Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Průmyslova 595, 252 50, Vestec, Czech Republic. olga.zbodakova@img.cas.cz
245    10
$a ADAM10 and ADAM17 regulate EGFR, c-Met and TNF RI signalling in liver regeneration and fibrosis / $c O. Zbodakova, K. Chalupsky, L. Sarnova, P. Kasparek, M. Jirouskova, M. Gregor, R. Sedlacek
520    9_
$a ADAM10 and ADAM17 are proteases that affect multiple signalling pathways by releasing molecules from the cell surface. As their substrate specificities partially overlaps, we investigated their concurrent role in liver regeneration and fibrosis, using three liver-specific deficient mouse lines: ADAM10- and ADAM17-deficient lines, and a line deficient for both proteases. In the model of partial hepatectomy, double deficient mice exhibited decreased AKT phosphorylation, decreased release of EGFR activating factors and lower shedding of HGF receptor c-Met. Thus, simultaneous ablation of ADAM10 and ADAM17 resulted in inhibited EGFR signalling, while HGF/c-Met signalling pathway was enhanced. In contrast, antagonistic effects of ADAM10 and ADAM17 were observed in the model of chronic CCl4 intoxication. While ADAM10-deficient mice develop more severe fibrosis manifested by high ALT, AST, ALP and higher collagen deposition, combined deficiency of ADAM10 and ADAM17 surprisingly results in comparable degree of liver damage as in control littermates. Therefore, ADAM17 deficiency is not protective in fibrosis development per se, but can ameliorate the damaging effect of ADAM10 deficiency on liver fibrosis development. Furthermore, we show that while ablation of ADAM17 resulted in decreased shedding of TNF RI, ADAM10 deficiency leads to increased levels of soluble TNF RI in serum. In conclusion, hepatocyte-derived ADAM10 and ADAM17 are important regulators of growth receptor signalling and TNF RI release, and pathological roles of these proteases are dependent on the cellular context.
650    _2
$a protein ADAM10 $x fyziologie $7 D000072197
650    _2
$a protein ADAM17 $x fyziologie $7 D000072198
650    _2
$a sekretasy $x fyziologie $7 D053829
650    _2
$a zvířata $7 D000818
650    _2
$a kultivované buňky $7 D002478
650    _2
$a fibróza $x metabolismus $7 D005355
650    12
$a játra $x metabolismus $x patologie $7 D008099
650    12
$a nemoci jater $x metabolismus $x patologie $7 D008107
650    12
$a regenerace jater $7 D008115
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové proteiny $x fyziologie $7 D008565
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a primární buněčná kultura $7 D061251
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Chalupsky, Karel $u Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Průmyslova 595, 252 50, Vestec, Czech Republic $u Czech Centre of Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Průmyslova 595, 252 50, Vestec, Czech Republic
700    1_
$a Sarnova, Lenka $u Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Průmyslova 595, 252 50, Vestec, Czech Republic $u Laboratory of Integrative Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20, Prague, Czech Republic
700    1_
$a Kasparek, Petr $u Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Průmyslova 595, 252 50, Vestec, Czech Republic $u Czech Centre of Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Průmyslova 595, 252 50, Vestec, Czech Republic
700    1_
$a Jirouskova, Marketa $u Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Průmyslova 595, 252 50, Vestec, Czech Republic $u Laboratory of Integrative Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20, Prague, Czech Republic
700    1_
$a Gregor, Martin $u Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Průmyslova 595, 252 50, Vestec, Czech Republic $u Laboratory of Integrative Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20, Prague, Czech Republic
700    1_
$a Sedlacek, Radislav $u Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, Průmyslova 595, 252 50, Vestec, Czech Republic. radislav.sedlacek@img.cas.cz $u Czech Centre of Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Průmyslova 595, 252 50, Vestec, Czech Republic. radislav.sedlacek@img.cas.cz
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 11, č. 1 (2021), s. 11414
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34075077 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145349 $b ABA008
999    __
$a ok $b bmc $g 1751690 $s 1155447
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 1 $d 11414 $e 20210601 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...